SBC Medical Group Holdings Incorporated(SBC)Earnings, Financials & Key Ratios
SBC•NASDAQ
$3.22
$330M mkt cap·6.7× P/E·Price updated May 6, 2026
AboutSBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.Show more
- Revenue$205M+6.1%
- EBITDA$74M-10.6%
- Net Income$47M+18.4%
- EPS (Diluted)0.48+15.5%
- Gross Margin75.97%+7.1%
- EBITDA Margin36.07%-15.8%
- Operating Margin34.23%-6.3%
- Net Margin22.69%+11.6%
- ROE27.51%-12.1%
- ROIC72.31%-7.3%
- Debt/Equity0.06-60.6%
- Interest Coverage2484.23+59.2%
SBC Key Insights
SBC Medical Group Holdings Incorporated (SBC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Excellent 3Y average ROE of 21.6%
- ✓Strong Piotroski F-Score: 7/9
- ✓Healthy 5Y average net margin of 15.6%
✗Weaknesses
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SBC Price & Volume
SBC Medical Group Holdings Incorporated (SBC) stock price & volume — 10-year historical chart
Loading chart...
SBC Growth Metrics
SBC Medical Group Holdings Incorporated (SBC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-20.1%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-20.38%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-27.17%
Return on Capital
10 Years34.23%
5 Years34.23%
3 Years34.23%
Last Year37.87%
SBC Recent Earnings
SBC Medical Group Holdings Incorporated (SBC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (50%)●Beat Revenue 1/12 qtrs (17%)
Q2 2026Latest
Mar 27, 2026EPS
$0.14
Est $0.13
+7.7%
Revenue
$40M
Est $45M
-12.9%
Q4 2025
Nov 14, 2025EPS
$0.12
Est $0.13
-7.7%
Revenue
$43M
Est $45M
-4.1%
Q3 2025
Aug 13, 2025EPS
$0.02
Est $0.14
-85.7%
Revenue
$43M
Est $46M
-5.0%
Q2 2025
May 15, 2025EPS
$0.21
Est $0.11
+90.9%
Revenue
$47M
Est $45M
+5.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 27, 2026 | $0.14vs $0.13+7.7% | $40Mvs $45M-12.9% |
| Q4 2025 | Nov 14, 2025 | $0.12vs $0.13-7.7% | $43Mvs $45M-4.1% |
| Q3 2025 | Aug 13, 2025 | $0.02vs $0.14-85.7% | $43Mvs $46M-5.0% |
| Q2 2025 | May 15, 2025 | $0.21vs $0.11+90.9% | $47Mvs $45M+5.9% |
Based on last 12 quarters of dataView full earnings history →
SBC Peer Comparison
SBC Medical Group Holdings Incorporated (SBC) competitors in Operations and human capital consulting — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SKIN | 120.86M | 0.93 | -5.83 | -10.02% | -3.16% | -15.42% | 6.20 | |
 INMD | 861.05M | 13.59 | 9.50 | -6.16% | 25.33% | 14.52% | 0.02 | |
 SSKN | 5.14M | 0.14 | -0.52 | 0.61% | -35.64% | -8.4% | 3.31 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 LASE | 16.46M | 0.74 | -3.37 | -13.31% | -105.37% | -183.55% | 0.49 | |
 AEYE | 95.09M | 7.66 | -30.64 | 14.52% | -7.63% | -47.8% | 0.15 | |
 ISRG | 160.44B | 451.73 | 57.40 | 20.51% | 28.15% | 16.89% | 0.02 | |
 EW | 47.97B | 83.20 | 45.46 | 11.55% | 17.64% | 10.35% | 0.07 |
Compare SBC vs Peers
SBC Medical Group Holdings Incorporated (SBC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SBC Income Statement
SBC Medical Group Holdings Incorporated (SBC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|
| Sales/Revenue | 174.16M | 193.54M | 205.42M | 178.46M |
| Revenue Growth % | - | 11.13% | 6.13% | -20.1% |
| Cost of Goods Sold | 59.33M | 56.24M | 49.37M | 46.94M |
| COGS % of Revenue | 34.06% | 29.06% | 24.03% | - |
| Gross Profit | 114.83M▲ 0% | 137.3M▲ 19.6% | 156.05M▲ 13.7% | 131.52M▲ 0% |
| Gross Margin % | 65.94% | 70.94% | 75.97% | 73.69% |
| Gross Profit Growth % | - | 19.57% | 13.65% | - |
| Operating Expenses | 94.72M | 66.64M | 85.75M | 72.16M |
| OpEx % of Revenue | 54.38% | 34.43% | 41.74% | - |
| Selling, General & Admin | 93.48M | 66.23M | 70.09M | 55.14M |
| SG&A % of Revenue | 53.68% | 34.22% | 34.12% | - |
| Research & Development | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - |
| Other Operating Expenses | 1.23M | 409.03K | 15.66M | 2.71M |
| Operating Income | 20.12M▲ 0% | 70.66M▲ 251.2% | 70.3M▼ 0.5% | 59.36M▲ 0% |
| Operating Margin % | 11.55% | 36.51% | 34.23% | 33.26% |
| Operating Income Growth % | - | 251.24% | -0.5% | - |
| EBITDA | 26.05M | 82.91M | 74.1M | 62.27M |
| EBITDA Margin % | 14.96% | 42.84% | 36.07% | 34.89% |
| EBITDA Growth % | - | 218.27% | -10.62% | -34.46% |
| D&A (Non-Cash Add-back) | 5.93M | 12.25M | 3.8M | 2.91M |
| EBIT | 23.71M | 73.62M | 73.48M | 69.67M |
| Net Interest Income | 440.94K | 41.46K | -8.36K | 81.7K |
| Interest Income | 472.38K | 86.75K | 19.94K | 198.6K |
| Interest Expense | 31.44K | 45.29K | 28.3K | 116.89K |
| Other Income/Expense | 3.56M | 2.92M | 3.15M | 10.2M |
| Pretax Income | 23.68M▲ 0% | 73.58M▲ 210.8% | 73.46M▼ 0.2% | 69.56M▲ 0% |
| Pretax Margin % | 13.59% | 38.02% | 35.76% | 38.98% |
| Income Tax | 18.12M | 35.02M | 26.77M | 26.24M |
| Effective Tax Rate % | 76.55% | 47.59% | 36.44% | 37.73% |
| Net Income | 6.32M▲ 0% | 39.37M▲ 523.4% | 46.61M▲ 18.4% | 43.32M▲ 0% |
| Net Margin % | 3.63% | 20.34% | 22.69% | 24.28% |
| Net Income Growth % | - | 523.44% | 18.4% | -20.38% |
| Net Income (Continuing) | 5.55M | 38.56M | 46.69M | 43.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 2.6M | 1.65M | -87K | 70.91K |
| EPS (Diluted) | 0.04▲ 0% | 0.42▲ 1039.0% | 0.48▲ 15.5% | 0.42▲ 0% |
| EPS Growth % | - | 1038.96% | 15.48% | -27.17% |
| EPS (Basic) | 0.04 | 0.42 | 0.48 | - |
| Diluted Shares Outstanding | 15.07M | 94.19M | 96.56M | 102.64M |
| Basic Shares Outstanding | 15.07M | 94.19M | 96.56M | 102.64M |
| Dividend Payout Ratio | - | - | - | - |
SBC Balance Sheet
SBC Medical Group Holdings Incorporated (SBC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|
| Total Current Assets | 112.95M | 165.91M | 184.45M | 227.2M |
| Cash & Short-Term Investments | 53.64M | 103.02M | 125.04M | 127.43M |
| Cash Only | 51.74M | 103.02M | 125.04M | 127.43M |
| Short-Term Investments | 1.91M | 0 | 0 | 0 |
| Accounts Receivable | 43.65M | 53.13M | 48.19M | 82.55M |
| Days Sales Outstanding | 91.47 | 100.2 | 85.63 | 138.55 |
| Inventory | 1.35M | 3.09M | 1.49M | 1.68M |
| Days Inventory Outstanding | 8.31 | 20.06 | 11.05 | 12.78 |
| Other Current Assets | 37.23K | 162.12K | 25.54K | 15.55M |
| Total Non-Current Assets | 112.53M | 92.9M | 81.63M | 94.16M |
| Property, Plant & Equipment | 21.51M | 19.5M | 14.04M | 12.36M |
| Fixed Asset Turnover | 8.10x | 9.92x | 14.63x | 13.28x |
| Goodwill | 3.87M | 3.59M | 4.61M | 4.92M |
| Intangible Assets | 7.27M | 19.74M | 1.59M | 23.3M |
| Long-Term Investments | 916.03K | 20.66M | 20.87M | 89.72M |
| Other Non-Current Assets | 73.7M | 29.41M | 30.72M | 113.24M |
| Total Assets | 225.48M▲ 0% | 258.81M▲ 14.8% | 266.08M▲ 2.8% | 321.36M▲ 0% |
| Asset Turnover | 0.77x | 0.75x | 0.77x | 0.60x |
| Asset Growth % | - | 14.78% | 2.81% | 49.54% |
| Total Current Liabilities | 101.25M | 92.45M | 61.19M | 44.58M |
| Accounts Payable | 15.32M | 26.53M | 14.53M | 20.1M |
| Days Payables Outstanding | 94.26 | 172.2 | 107.46 | 142.22 |
| Short-Term Debt | 4.76M | 3.53M | 123.08K | 4.68M |
| Deferred Revenue (Current) | 30.44M | 25.13M | 12.56M | 34.09M |
| Other Current Liabilities | 25.2M | 832.52K | 227.89K | 12.46M |
| Current Ratio | 1.12x | 1.79x | 3.01x | 3.01x |
| Quick Ratio | 1.10x | 1.76x | 2.99x | 2.99x |
| Cash Conversion Cycle | 5.52 | -51.94 | -10.78 | 9.1 |
| Total Non-Current Liabilities | 16.38M | 22.54M | 9.87M | 28.72M |
| Long-Term Debt | 5.53M | 13.01M | 6.51M | 18.08M |
| Capital Lease Obligations | 2.36M | 2.44M | 1.24M | 5.82M |
| Deferred Tax Liabilities | 7.34M | 6.01M | 926.02K | 1.63M |
| Other Non-Current Liabilities | 1.15M | 1.07M | 1.19M | 12.49M |
| Total Liabilities | 117.63M | 115M | 71.06M | 73.3M |
| Total Debt | 16.13M | 22.87M | 12.21M | 28.15M |
| Net Debt | -35.61M | -80.16M | -112.83M | -99.28M |
| Debt / Equity | 0.15x | 0.16x | 0.06x | 0.06x |
| Debt / EBITDA | 0.62x | 0.28x | 0.16x | 0.45x |
| Net Debt / EBITDA | -1.37x | -0.97x | -1.52x | -1.52x |
| Interest Coverage | 639.85x | 1560.10x | 2484.23x | 596.05x |
| Total Equity | 107.85M▲ 0% | 143.81M▲ 33.3% | 195.02M▲ 35.6% | 248.06M▲ 0% |
| Equity Growth % | - | 33.34% | 35.61% | 158.33% |
| Book Value per Share | 7.16 | 1.53 | 2.02 | 2.42 |
| Total Shareholders' Equity | 105.25M | 142.16M | 195.11M | 247.99M |
| Common Stock | 0 | 9.42K | 10.3K | 10.39K |
| Retained Earnings | 103.48M | 142.85M | 189.46M | 226.25M |
| Treasury Stock | 0 | 0 | -2.7M | -7.75M |
| Accumulated OCI | -24.85M | -37.58M | -54.18M | -42.72M |
| Minority Interest | 2.6M | 1.65M | -87K | 70.91K |
SBC Cash Flow Statement
SBC Medical Group Holdings Incorporated (SBC) cash flow — operating, investing & free cash flow history
| Line item | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|
| Cash from Operations | -47.37K | 50.64M | 20.58M | 20.58M |
| Operating CF Margin % | -0.03% | 26.17% | 10.02% | - |
| Operating CF Growth % | - | 107012.84% | -59.36% | -833.99% |
| Net Income | 5.55M | 39.37M | 46.61M | 43.32M |
| Depreciation & Amortization | 5.93M | 12.25M | 3.8M | 2.91M |
| Stock-Based Compensation | 0 | 0 | 13.02M | 215.24K |
| Deferred Taxes | -3.9M | 4.11M | -14.42M | -4.81M |
| Other Non-Cash Items | 2.96M | 2.59M | -16.31M | -20.63M |
| Working Capital Changes | -10.59M | -7.68M | -12.13M | -55.6M |
| Change in Receivables | -9.6M | -6.01M | 13.1M | -28.01M |
| Change in Inventory | -666.64K | -1.83M | 1.12M | 626.78K |
| Change in Payables | 172.61K | 12.2M | -8.91M | 5.23M |
| Cash from Investing | -32.65M | 1.82M | -10.1M | -1.31M |
| Capital Expenditures | -24.95M | -9.52M | -3.41M | -2.03M |
| CapEx % of Revenue | 14.32% | 4.92% | 1.66% | - |
| Acquisitions | -6.49M | 722.55K | -5.07M | -17.69M |
| Investments | - | - | - | - |
| Other Investing | 1.43M | 8.6M | -1.29M | 19.49M |
| Cash from Financing | -7.98M | 6.14M | 22.97M | 29.85M |
| Debt Issued (Net) | -5.08M | 3.58M | 6.48M | 11.08M |
| Equity Issued (Net) | 1000K | 10 | 31.37K | -2M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -5M |
| Other Financing | -121.72M | 2.56M | 16.45M | 23.77M |
| Net Change in Cash | -52.77M▲ 0% | 51.28M▲ 197.2% | 22.02M▼ 57.1% | -9.96M▲ 0% |
| Free Cash Flow | -24.99M▲ 0% | 39.44M▲ 257.8% | 17.17M▼ 56.4% | -36.63M▲ 0% |
| FCF Margin % | -14.35% | 20.38% | 8.36% | -20.53% |
| FCF Growth % | - | 257.79% | -56.45% | -179.38% |
| FCF per Share | -1.66 | 0.42 | 0.18 | 0.18 |
| FCF Conversion (FCF/Net Income) | -0.01x | 1.29x | 0.44x | -0.85x |
| Interest Paid | 31.44K | 45.29K | 28.3K | 116.89K |
| Taxes Paid | 30.82M | 17.84M | 30.24M | 18.54M |
SBC Key Ratios
SBC Medical Group Holdings Incorporated (SBC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2023 | 2024 | TTM |
|---|---|---|---|
| Return on Equity (ROE) | 31.29% | 27.51% | 17.47% |
| Return on Invested Capital (ROIC) | 77.99% | 72.31% | 72.31% |
| Gross Margin | 70.94% | 75.97% | 73.69% |
| Net Margin | 20.34% | 22.69% | 24.28% |
| Debt / Equity | 0.16x | 0.06x | 0.06x |
| Interest Coverage | 1560.10x | 2484.23x | 596.05x |
| FCF Conversion | 1.29x | 0.44x | -0.85x |
| Revenue Growth | 11.13% | 6.13% | -20.1% |
SBC Frequently Asked Questions
SBC Medical Group Holdings Incorporated (SBC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SBC Medical Group Holdings Incorporated (SBC) reported $178.5M in revenue for fiscal year 2024. This represents a 2% increase from $174.2M in 2022.
SBC Medical Group Holdings Incorporated (SBC) grew revenue by 6.1% over the past year. This is steady growth.
Yes, SBC Medical Group Holdings Incorporated (SBC) is profitable, generating $43.3M in net income for fiscal year 2024 (22.7% net margin).
Dividend & Returns
SBC Medical Group Holdings Incorporated (SBC) has a return on equity (ROE) of 27.5%. This is excellent, indicating efficient use of shareholder capital.
SBC Medical Group Holdings Incorporated (SBC) had negative free cash flow of $36.6M in fiscal year 2024, likely due to heavy capital investments.
Explore More SBC
SBC Medical Group Holdings Incorporated (SBC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates